A team led by the Lawrence Livermore scientists has created a new kind of ion channel consisting of short carbon nanotubes, which can be inserted into synthetic bilayers and live cell membranes to form tiny pores that transport water, protons, small ions and DNA.
These carbon nanotube "porins" have significant implications for future health care and bioengineering applications. Nanotube porins eventually could be used to deliver drugs to the body, serve as a foundation of novel biosensors and DNA sequencing applications, and be used as components of synthetic cells.
Researchers have long been interested in developing synthetic analogs of biological membrane channels that could replicate high efficiency and extreme selectivity for transporting ions and molecules that are typically found in natural systems. However, these efforts always involved problems working with synthetics and they never matched the capabilities of biological proteins.
Unlike taking a pill which is absorbed slowly and is delivered to the entire body, carbon nanotubes can pinpoint an exact area to treat without harming surrounding other organs.
"Many good and efficient drugs that treat diseases of one organ are quite toxic to another," said Aleksandr Noy, an LLNL biophysicist who led the study and is the senior author on the paper appearing in the Oct. 30 issue of the journal, Nature. "This is why delivery to a particular part of the body and only releasing it there is much better."
This research showed that despite their structural simplicity, CNT porins display many characteristic behaviors of natural ion channels: they spontaneously insert into the membranes, switch between metastable conductance states, and display characteristic macromolecule-induced blockades. The team also found that, just like in the biological channels, local channel and membrane charges could control the ionic conductance and ion selectivity of the CNT porins.
"We found that these nanopores are a promising biomimetic platform for developing cell interfaces, studying transport in biological channels, and creating biosensors," Noy said. "We are thinking about CNT porins as a first truly versatile synthetic nanopore that can create a range of applications in biology and materials science."
"Taken together, our findings establish CNT porins as a promising prototype of a synthetic membrane channel with inherent robustness toward biological and chemical challenges and exceptional biocompatibility that should prove valuable for bionanofluidic and cellular interface applications," said Jia Geng, a postdoc who is one of the first co-authors of the paper.
Kyunghoon Kim, a postdoc and another first co-author, added: "We also expect that our CNT porins could be modified with synthetic 'gates' to dramatically alter their selectivity, opening up exciting possibilities for their use in synthetic cells, drug delivery and biosensing."
Other LLNL researchers include Ramya Tunuguntla, Kang Rae Cho, Dayannara Munoz and Morris Wang. The team members performed some of the work at the Molecular Foundry DOE user facility as a part of its user project.
The work is funded by the DOE Office of Science and LLNL's Laboratory Directed Research and Development Program.